Semaglutide 10mg

Semaglutide is a synthetic 31-amino-acid polypeptide designed as a glucagon-like peptide-1 (GLP-1) receptor agonist. It features an Aib substitution at position 8 for DPP-4 resistance, an arginine replacement at position 34, and a C18 fatty diacid chain attached via a γGlu-2×OEG linker to lysine at position 26, promoting albumin binding and extended half-life for once-weekly dosing. Research has examined its effects on glucose-dependent insulin secretion, glucagon suppression, gastric emptying delay, appetite regulation, glycemic control, and body weight reduction in preclinical and clinical models. This 10mg lyophilized preparation is intended strictly for in vitro research and laboratory investigation. Not for human consumption.